159 related articles for article (PubMed ID: 15782103)
1. Rat experimental model of continuous regional arterial infusion of protease inhibitor and its effects on severe acute pancreatitis.
Mikami Y; Takeda K; Matsuda K; Qiu-Feng H; Fukuyama S; Egawa S; Sunamura M; Matsuno S
Pancreas; 2005 Apr; 30(3):248-53. PubMed ID: 15782103
[TBL] [Abstract][Full Text] [Related]
2. Regional effects of nafamostat, a novel potent protease and complement inhibitor, on severe necrotizing pancreatitis.
Keck T; Balcom JH; Antoniu BA; Lewandrowski K; Warshaw AL; Fernández-del Castillo CF
Surgery; 2001 Aug; 130(2):175-81. PubMed ID: 11490346
[TBL] [Abstract][Full Text] [Related]
3. Continuous regional arterial infusion of protease inhibitor and antibiotics in acute necrotizing pancreatitis.
Takeda K; Matsuno S; Sunamura M; Kakugawa Y
Am J Surg; 1996 Apr; 171(4):394-8. PubMed ID: 8604829
[TBL] [Abstract][Full Text] [Related]
4. The results of severe acute pancreatitis treatment with continuous regional arterial infusion of protease inhibitor and antibiotic: a randomized controlled study.
Piaścik M; Rydzewska G; Milewski J; Olszewski S; Furmanek M; Walecki J; Gabryelewicz A
Pancreas; 2010 Aug; 39(6):863-7. PubMed ID: 20431422
[TBL] [Abstract][Full Text] [Related]
5. Continuous regional arterial infusion versus intravenous administration of the protease inhibitor nafamostat mesilate for predicted severe acute pancreatitis: a multicenter, randomized, open-label, phase 2 trial.
Hirota M; Shimosegawa T; Kitamura K; Takeda K; Takeyama Y; Mayumi T; Ito T; Takenaka M; Iwasaki E; Sawano H; Ishida E; Miura S; Masamune A; Nakai Y; Mitoro A; Maguchi H; Kimura K; Sanuki T; Ito T; Haradome H; Kozaka K; Gabata T; Kataoka K; Hirota M; Isaji S; Nakamura R; Yamagiwa K; Kayaba C; Ikeda K
J Gastroenterol; 2020 Mar; 55(3):342-352. PubMed ID: 31758329
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of continuous regional arterial infusion of a protease inhibitor and antibiotic for severe acute pancreatitis in patients admitted to an intensive care unit.
Imaizumi H; Kida M; Nishimaki H; Okuno J; Kataoka Y; Kida Y; Soma K; Saigenji K
Pancreas; 2004 May; 28(4):369-73. PubMed ID: 15097852
[TBL] [Abstract][Full Text] [Related]
7. [Continuous regional arterial infusion of protease inhibitor and antibiotic for severe acute pancreatitis].
Takeda K
Nihon Rinsho; 2004 Nov; 62(11):2101-7. PubMed ID: 15552895
[TBL] [Abstract][Full Text] [Related]
8. [Effect of continuous arterial infusion of protease inhibitor on experimental acute pancreatitis induced by closed duodenal loop obstruction].
Kakugawa Y; Takeda K; Sunamura M; Kawaguchi S; Kobari M; Matsuno S
Nihon Shokakibyo Gakkai Zasshi; 1990 Jun; 87(6):1444-50. PubMed ID: 2214268
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacy of continuous i.v. infusion versus continuous regional arterial infusion of nafamostat mesylate for severe acute pancreatitis.
Yamamoto T; Yamamura H; Yamamoto H; Mizobata Y
Acute Med Surg; 2016 Jul; 3(3):237-243. PubMed ID: 29123791
[TBL] [Abstract][Full Text] [Related]
10. Continuous regional arterial infusion for the treatment of severe acute pancreatitis: a meta-analysis.
Yong FJ; Mao XY; Deng LH; Zhang MM; Xia Q
Hepatobiliary Pancreat Dis Int; 2015 Feb; 14(1):10-7. PubMed ID: 25655286
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of nafamostat and imipenem on experimental acute pancreatitis in rats.
Naruse S; Wang Y; Kitagawa M; Ishiguro H; Seki Y; Ozaki T; Hayakawa T
Pancreas; 2000 Oct; 21(3):290-5. PubMed ID: 11039474
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy of continuous arterial infusion of an antibiotic and a protease inhibitor via the superior mesenteric artery for acute pancreatitis in an animal model.
Takagi K; Isaji S
Pancreas; 2000 Oct; 21(3):279-89. PubMed ID: 11039473
[TBL] [Abstract][Full Text] [Related]
13. Role of early continuous regional arterial infusion of protease inhibitor and antibiotic in nonsurgical treatment of acute necrotizing pancreatitis.
Takeda K; Sunamura M; Shibuya K; Kobari M; Matsuno S
Digestion; 1999; 60 Suppl 1():9-13. PubMed ID: 10026424
[TBL] [Abstract][Full Text] [Related]
14. Impact of continuous regional arterial infusion in the treatment of acute necrotizing pancreatitis: analysis of a national administrative database.
Endo A; Shiraishi A; Fushimi K; Murata K; Otomo Y
J Gastroenterol; 2018 Sep; 53(9):1098-1106. PubMed ID: 29564566
[TBL] [Abstract][Full Text] [Related]
15. Continuous regional application of protease inhibitor in the treatment of acute pancreatitis. An experimental study using closed duodenal obstruction model in dogs.
Yamauchi J; Takeda K; Shibuya K; Sunamura M; Matsuno S
Pancreatology; 2001; 1(6):662-7. PubMed ID: 12120251
[TBL] [Abstract][Full Text] [Related]
16. [Effects of E-3123, a new protease inhibitor, on several protease activities and on experimental acute pancreatitis].
Miyamoto K; Hishinuma I; Nagakawa J; Nagaoka N; Yamanaka T; Wakabayashi T
Nihon Yakurigaku Zasshi; 1988 May; 91(5):285-93. PubMed ID: 3410375
[TBL] [Abstract][Full Text] [Related]
17. Effects of nafamostat mesilate on the prevention of cerulein-induced acute pancreatitis.
Lee JK; Ryu JK; Park JK; Lee SH; Yoon WJ; Kim YT; Jung HC; Yoon YB
Pancreas; 2008 Apr; 36(3):255-60. PubMed ID: 18362838
[TBL] [Abstract][Full Text] [Related]
18. New strategy for acute necrotizing pancreatitis: Continuous Regional Arterial Infusion (CRAI) therapy.
Mikami Y; Takeda K; Omura N; Abe H; Fukuyama S; Motoi F; Egawa S; Sunamura M; Matsuno S
Rocz Akad Med Bialymst; 2005; 50():101-5. PubMed ID: 16358947
[TBL] [Abstract][Full Text] [Related]
19. [Marked improvement of "severe acute pancreatitis" with continuous administration of protease inhibitor: nafamostat mesilate (Futhan) via intraarterial infusion in a case].
Kawasaki K; Arimura Y; Hirata H; Suzuki T; Kakumoto Y; Kaneto H; Mihara M; Imai K
Nihon Shokakibyo Gakkai Zasshi; 1996 Aug; 93(8):588-93. PubMed ID: 8810819
[No Abstract] [Full Text] [Related]
20. Continuous regional arterial infusion therapy with gabexate mesilate for severe acute pancreatitis.
Ino Y; Arita Y; Akashi T; Kimura T; Igarashi H; Oono T; Furukawa M; Kawabe K; Ogoshi K; Ouchi J; Miyahara T; Takayanagi R; Ito T
World J Gastroenterol; 2008 Nov; 14(41):6382-7. PubMed ID: 19009656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
